Why is Suraksha Diagnostic Ltd falling/rising?

Recent Price Movement and Market Comparison

Suraksha Diagnostic Ltd has experienced a notable decline over the past week, with the stock losing 6.54% compared to the Sensex’s 3.67% fall. Although the stock’s one-month performance of -1.65% is roughly in line with the Sensex’s -1.75%, the year-to-date return of -0.95% contrasts with the broader market’s sharper 5.85% decline, indicating relative resilience. However, over the last year, the stock’s 2.17% gain significantly trails the Sensex’s 9.62% rise, highlighting underperformance against the benchmark.

On 02-Mar, the stock opened sharply lower, down 16.03%, and traded within a wide intraday range of ₹40.85, touching the low of ₹227.95. The weighted average price suggests that most trading volume occurred near the day’s low, signalling selling pressure. Furthermore, Suraksha Diagnostic is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating a bearish technical outlook.

Investor Participation and Liquidity Concerns

Investor participation appears to be waning, with delivery volumes on 27 Feb falling by 56.65% compared to the five-day average. This decline in investor engagement may exacerbate price volatility and contribute to the downward momentum. Despite this, liquidity remains sufficient for small trade sizes, with the stock’s traded value supporting transactions of approximately ₹0.01 crore based on 2% of the five-day average traded value.

Fundamental Strengths Amidst Challenges

Despite the recent price weakness, Suraksha Diagnostic Ltd maintains several positive fundamental attributes. The company demonstrates a strong ability to service its debt, with a low Debt to EBITDA ratio of 0.87 times, suggesting manageable leverage. Operating profit has grown at an impressive annual rate of 89.29%, reflecting healthy long-term growth prospects. Additionally, the company’s return on capital employed (ROCE) stands at a robust 15.8%, supported by an attractive enterprise value to capital employed ratio of 4.8. Institutional investors hold a significant 36.03% stake, indicating confidence from knowledgeable market participants.

Over the past year, while the stock’s price appreciation has been modest at 2.17%, the company’s profits have risen by 34%, signalling improving operational performance that has yet to be fully reflected in the share price.

Reasons Behind the Recent Decline

However, the stock’s recent decline can be largely attributed to disappointing quarterly and half-year financial metrics reported in December 2025. The operating profit to interest coverage ratio fell to a low of 7.33 times, while the debt-equity ratio increased to 0.51 times, the highest in recent periods. Interest expenses also rose to ₹3.16 crore, indicating increased financial costs that may pressure profitability.

Moreover, the stock has underperformed the broader market over the last year, generating a 2.17% return compared to the BSE500’s 14.43% gain. This relative underperformance may have dampened investor sentiment, contributing to the recent selling pressure and the stock’s failure to sustain higher price levels.

Outlook for Investors

In summary, Suraksha Diagnostic Ltd’s recent share price decline is driven by a combination of weak quarterly financial results, increased interest costs, and underperformance relative to market indices. The stock’s technical indicators and falling investor participation further compound the bearish sentiment. Nonetheless, the company’s strong long-term profit growth, solid debt servicing capability, and institutional backing provide some fundamental support.

Investors should weigh these contrasting factors carefully. While the stock currently faces downward pressure, its attractive valuation metrics and improving profitability could offer opportunities for patient investors. Monitoring upcoming quarterly results and market sentiment will be crucial to assess whether the stock can stabilise and regain momentum.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →